Blood test could predict response of HPV-positive head and neck cancer to treatment

Researchers have developed a blood test that can detect whether patients with a type of locally advanced (non-metastatic) head and neck cancer have residual tumours after chemotherapy and radiotherapy.
Institute of Cancer Research

Comments